Somewhat Positive Press Coverage Somewhat Unlikely to Affect Cutera (CUTR) Share Price
Media stories about Cutera (NASDAQ:CUTR) have been trending somewhat positive on Monday, according to Accern Sentiment Analysis. The research firm identifies positive and negative media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Cutera earned a coverage optimism score of 0.13 on Accern’s scale. Accern also gave media headlines about the medical device company an impact score of 45.6097243913138 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
CUTR has been the topic of several recent research reports. Roth Capital increased their price target on Cutera from $41.00 to $47.00 and gave the company a “buy” rating in a report on Tuesday, September 12th. BidaskClub upgraded Cutera from a “hold” rating to a “buy” rating in a research note on Tuesday, December 12th. Maxim Group reiterated a “hold” rating on shares of Cutera in a research note on Wednesday, November 8th. Finally, Zacks Investment Research lowered Cutera from a “buy” rating to a “hold” rating in a research note on Tuesday, October 10th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $37.33.
Cutera (NASDAQ CUTR) traded up $0.20 during mid-day trading on Monday, reaching $47.40. The company’s stock had a trading volume of 645,500 shares, compared to its average volume of 162,876. Cutera has a twelve month low of $16.55 and a twelve month high of $48.95. The stock has a market capitalization of $656.73, a price-to-earnings ratio of 60.77, a price-to-earnings-growth ratio of 2.05 and a beta of 0.53.
In related news, EVP Miguel Pardos sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, December 12th. The stock was sold at an average price of $46.70, for a total transaction of $467,000.00. Following the sale, the executive vice president now owns 39,698 shares of the company’s stock, valued at $1,853,896.60. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Timothy J. Oshea sold 4,000 shares of the firm’s stock in a transaction dated Monday, October 16th. The shares were sold at an average price of $39.21, for a total value of $156,840.00. The disclosure for this sale can be found here. Insiders have sold a total of 23,950 shares of company stock worth $1,038,320 in the last three months. Corporate insiders own 11.60% of the company’s stock.
Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.